Public Health and Disease Control
<h1>Public Health and Disease Control</h1>
<p>Singapore's public health system covers population-level prevention, surveillance, and control of infectious and environmental health threats — work that sits alongside, but is distinct from, the hospital-centric clinical system described in <a href="/en/knowledge/article/sgkb.healthcare.healthcare-system-overview">healthcare system overview</a>. Where <a href="/en/knowledge/article/sgkb.healthcare.hospitals">hospitals</a> and <a href="/en/knowledge/article/sgkb.healthcare.polyclinics-and-primary-care">polyclinics and primary care</a> treat individual patients, public health agencies watch whole populations: mandating disease notification, running national vaccination schedules, inspecting food premises, suppressing mosquito vectors, and coordinating outbreak response. Since <strong>April 2025</strong>, the <strong>Communicable Diseases Agency (CDA)</strong> is the dedicated public health authority for communicable diseases under the Ministry of Health (MOH), consolidating infectious-disease functions previously spread across MOH headquarters, the <strong>Health Promotion Board (HPB)</strong>, and the National Centre for Infectious Diseases (NCID) (<a href="https://www.moh.gov.sg/newsroom/formation-of-communicable-diseases-agency-and-appointment-of-professor-vernon-lee-as-ceo/">MOH, Feb 2025</a>; <a href="https://www.cda.gov.sg/about-cda/who-we-are/">CDA, accessed Aug 2026</a>). HPB remains MOH’s statutory board for health promotion and chronic-disease prevention, while the National Environment Agency (NEA) continues as the national authority on environmental public health (<a href="https://www.hpb.gov.sg/about/about-us/">HPB, accessed Aug 2026</a>; <a href="https://www.nea.gov.sg/corporate-functions/who-we-are/groups-and-divisions/public-health-groups-and-divisions">NEA, accessed Aug 2026</a>). Agency-role anchors without invented outbreak tallies are in <a href="/en/knowledge/dataset/sgkb.data.public-health-agency-anchors">public health agency anchors</a>.</p>
<h2>The Communicable Diseases Agency</h2>
<p>The Communicable Diseases Agency, established in April 2025 as a statutory board under MOH, is Singapore's dedicated public health authority for communicable diseases (<a href="https://www.cda.gov.sg/about-cda/who-we-are/">CDA, accessed Aug 2026</a>). CDA consolidates detection, prevention, and control functions previously distributed across MOH headquarters, HPB, and NCID — a reorganisation announced during the 2023 parliamentary debate on Singapore's COVID-19 response and formally launched by the Prime Minister on 12 November 2025 (<a href="https://www.cda.gov.sg/news-and-events/official-launch-of-communicable-diseases-agency/">CDA launch, Nov 2025</a>). NCID continues as a clinical centre within the CDA structure, with its executive director reporting through the agency (<a href="https://www.cda.gov.sg/about-cda/who-we-are/">CDA, accessed Aug 2026</a>).</p>
<p>CDA's mandate spans five operational areas: <strong>prevent</strong> disease spread through vaccination policy, public education, and infection prevention; <strong>prepare</strong> sectoral readiness and access to vaccines and therapeutics; <strong>detect</strong> through strengthened surveillance including new modalities and data analytics; <strong>respond</strong> to cases and outbreaks with investigation, contact tracing, and public health measures; and <strong>enable</strong> these functions through research and international cooperation (<a href="https://www.moh.gov.sg/newsroom/formation-of-communicable-diseases-agency-and-appointment-of-professor-vernon-lee-as-ceo/">MOH, Feb 2025</a>). Early initiatives after becoming operational include the Singapore Pandemic Preparedness and Response Framework in July 2025 and a September 2025 update to the National Adult Immunisation Schedule adding Shingrix and PCV20 (<a href="https://www.cda.gov.sg/news-and-events/official-launch-of-communicable-diseases-agency/">CDA launch, Nov 2025</a>).</p>
<p>The split from HPB is structurally important for retrieval. HPB, established in 2001, remains MOH's agency for health promotion and disease prevention — nutrition, physical activity, mental well-being, health screening, tobacco control, and lifestyle programmes that support Healthier SG — but is <strong>not</strong> the lead infectious-disease surveillance and outbreak-control authority after CDA’s formation (<a href="https://www.hpb.gov.sg/about/about-us/">HPB, accessed Aug 2026</a>; <a href="/en/knowledge/dataset/sgkb.data.public-health-agency-anchors">public health agency anchors</a>). CDA owns communicable-disease epidemiology, the national immunisation policy schedules, outbreak investigation, and the National Public Health Laboratory. Clinical treatment of infected patients still flows through hospitals and primary care; CDA sets the population-level rules and coordinates the response around them. This article does not invent current outbreak case counts; for incidence, use the dated CDA surveillance release that matches the question’s period.</p>
<h2>Disease surveillance and outbreak response</h2>
<p>Singapore's principal legislation for infectious disease control is the <strong>Infectious Diseases Act (IDA)</strong>, jointly administered by MOH, the Singapore Food Agency (SFA), and NEA (<a href="https://www.cda.gov.sg/public/infectious-diseases-act/">CDA, accessed Aug 2026</a>). The IDA empowers the Director-General of Health to require notification of listed infectious diseases, isolate and treat infected persons, conduct contact tracing and quarantine, and order disinfection of premises. It provides a tiered hierarchy of responses — including declaration of a Public Health Threat or Public Health Emergency by the Minister for Health — so outbreak management can scale with severity. Port-of-entry measures to prevent disease importation are also stipulated under the Act.</p>
<p><strong>Notifiable disease surveillance</strong> is the backbone of detection. Licensed doctors and laboratories must report specified infectious diseases to the authorities; CDA publishes annual surveillance reports covering air/droplet-borne, vector-borne, food-borne, blood-borne, and sexually transmitted diseases, alongside programme coverage data (<a href="https://www.cda.gov.sg/resources/communicable-diseases-surveillance-singapore-2023-2024/">CDA surveillance report 2023–2024, Dec 2025</a>). Clinical case reporting is supplemented by environmental and laboratory modalities. NEA's Environmental Health Institute (EHI) runs arbovirus diagnostics, genomic surveillance of dengue virus serotypes, and a wastewater surveillance network covering more than 500 sampling sites — initiated in February 2020 for SARS-CoV-2 and expanded from mid-2023 to include Zika virus, in partnership with CDA and PUB (<a href="https://www.nea.gov.sg/corporate-functions/resources/research/environmental_health_institute/wastewater-surveillance-programme/">NEA wastewater programme, accessed Aug 2026</a>). Wastewater sampling can capture community-level transmission including from mildly symptomatic or asymptomatic individuals who may not seek care, complementing clinical surveillance.</p>
<p>When an outbreak is detected, CDA investigates cases, traces contacts, and recommends or implements control measures — the same operational chain exercised at scale during COVID-19 and in smaller episodes such as dengue clusters and food-borne incidents. NEA contributes vector-control operations and environmental disinfection during outbreaks; SFA handles food-safety enforcement where contaminated food is implicated. The IDA's tiered framework allows graduated measures — from targeted quarantine to economy-wide safe-management rules — without requiring ad hoc legislation for each crisis.</p>
<h2>Mask rules and respiratory-infection precautions</h2>
<p>Singapore has no blanket COVID-19 mask requirement for people in ordinary public places or on public transport: the temporary COVID-19 legal requirement was stepped down on <strong>13 February 2023</strong>. From <strong>1 March 2024</strong>, MOH also ended compulsory mask-wearing in lower-risk outpatient settings, including polyclinics, GP and specialist outpatient clinics, dialysis centres, TCM clinics and dental clinics. MOH says masks remain required in higher-risk healthcare settings — inpatient wards, emergency departments and residential-care facilities — to protect medically vulnerable people and older residents; hospital inpatients and care-home residents themselves are not required to wear one. In outpatient settings, MOH strongly encourages masking for medically vulnerable people, seniors and people with acute respiratory infection symptoms (<a href="https://www.moh.gov.sg/newsroom/integrating-our-covid-19-response-protocols-into-our-broader-public-health-programmes/">MOH, 29 Feb 2024</a>).</p>
<p>These are not the only possible rules: another regulator or a private organisation can set a mask requirement for its own premises or workforce. Separately, CDA's <strong>21 May 2026</strong> public advisory recommends wearing a mask when experiencing symptoms such as a runny nose, sore throat, headache or fever; this is infection-control advice, not a general public-place legal mandate. MOH also advises symptomatic people who need to go out to mask up, avoid crowded places and avoid contact with vulnerable people (<a href="https://www.cda.gov.sg/news-and-events/cda-statement--update-on-covid-19-situation-in-singapore/">CDA, 21 May 2026</a>; <a href="https://www.moh.gov.sg/newsroom/singapore-to-exit-acute-phase-of-pandemic/">MOH, 13 Feb 2023</a>). For a current facility-specific requirement, follow that facility's notice and the latest MOH/CDA direction; the 2020–2022 pandemic rules should not be read as today's general rule.</p>
<h2>Mask and respirator types: what the filtration figures mean</h2>
<p>HSA distinguishes loose-fitting cloth or paper face masks, surgical masks, N95 respirators and surgical N95 respirators by intended use, fit and test. A cloth or paper face mask mainly provides source control by reducing large particles expelled by the wearer. A surgical mask is a medical device, also supports source control and can act as a barrier against larger droplets or splashes, but it does not seal tightly to the face. HSA reports bacterial filtration efficiency above 95% for surgical masks under the relevant medical-mask standard. An N95 respirator instead forms a tight seal when correctly fitted and is certified to filter at least 95% of specified non-oil particulate aerosols around 0.3 microns; it is not tested for resistance to bodily-fluid splashes. A surgical N95 combines the respirator's particle protection with fluid resistance (<a href="https://www.hsa.gov.sg/announcements/guide-to-masks-and-respirators/">HSA, Guide to Masks and Respirators, 28 May 2026</a>; <a href="https://www.hsa.gov.sg/announcements/what-you-need-to-know-about-masks/">HSA, What You Need to Know About Masks, 28 May 2026</a>).</p>
<p>The percentages are results from different test methods and do <strong>not</strong> mean that a surgical mask and an N95 provide the same kind of 95% protection, or that either guarantees a wearer's real-world protection against every virus. Gaps around the face can let air bypass a filter; HSA says respirators require appropriate fit testing and a seal check. For haze particles, NEA likewise says N95-equivalent protection depends on a suitable, leak-free fit and is generally unnecessary for short outdoor commutes or indoor settings; its guidance is not a recommendation to wear N95 routinely for ordinary daily activity. People with breathing difficulty or relevant heart or lung conditions should follow NEA's current advice and consult a clinician where indicated (<a href="https://www.hsa.gov.sg/announcements/guide-to-masks-and-respirators/">HSA, Guide to Masks and Respirators, 28 May 2026</a>; <a href="https://www.nea.gov.sg/our-services/pollution-control/air-pollution/faqs">NEA, Haze FAQs, accessed 8 Nov 2026</a>).</p>
<h2>National immunisation programmes</h2>
<p>Singapore maintains two nationally recommended vaccination schedules reviewed by MOH in consultation with the Expert Committee on Immunisation (ECI): the <strong>National Childhood Immunisation Schedule (NCIS)</strong> and the <strong>National Adult Immunisation Schedule (NAIS)</strong>, published by CDA (<a href="https://www.cda.gov.sg/public/vaccinations/">CDA vaccinations, May 2026</a>). The NCIS covers 14 vaccine-preventable diseases — tuberculosis, hepatitis B, diphtheria, tetanus, pertussis, poliovirus, Haemophilus influenzae type b, measles, mumps, rubella, varicella, pneumococcal disease, human papillomavirus, and influenza — with age-specific dosing from birth through adolescence. Vaccinations against <strong>measles and diphtheria are compulsory</strong> for children under the IDA; that legal obligation is distinct from the broader set of vaccines recommended in the NCIS (<a href="https://www.cda.gov.sg/public/vaccinations/">CDA vaccinations, May 2026</a>; <a href="https://www.nir.cda.gov.sg/eservices/parentalfaq">CDA NIR FAQ, accessed Nov 2026</a>). The NAIS, established in November 2017, recommends vaccines for adults aged 18 and above against 12 diseases, with schedules tailored by age, occupation, medical conditions, and vaccination history (<a href="https://www.cda.gov.sg/public/vaccinations/">CDA vaccinations, May 2026</a>).</p>
<p>Vaccines are delivered through multiple channels. Childhood doses are given at birth in hospitals, at <a href="/en/knowledge/article/sgkb.healthcare.polyclinics-and-primary-care">polyclinics</a> and private paediatric clinics, and through a <strong>school-based programme</strong> in which Tdap, IPV, HPV (for females), and MMR catch-up vaccines are provided at Primary 5, Secondary 1, and Secondary 2 (<a href="https://www.cda.gov.sg/public/vaccinations/">CDA vaccinations, May 2026</a>). Adult and senior vaccinations are available at participating CHAS clinics and public healthcare institutions; nationally recommended vaccines under the NAIS and NCIS receive subsidies at public healthcare settings, and Healthier SG enrollees can access fully subsidised NAIS vaccines at their enrolled clinic (<a href="https://www.cda.gov.sg/public/vaccinations/">CDA vaccinations, May 2026</a>; see <a href="/en/knowledge/article/sgkb.healthcare.healthcare-financing">healthcare financing</a> for the wider subsidy framework). The <strong>National Immunisation Registry</strong> records vaccination history, accessible to residents through an online portal and used to verify immunisation status for foreign-born children applying for long-term immigration passes (<a href="https://www.cda.gov.sg/public/vaccinations/">CDA vaccinations, May 2026</a>). HPB continues to run public-education campaigns promoting adult immunisation — for example urging seniors to take subsidised pneumococcal vaccines under Healthier SG — but policy and schedule ownership sit with CDA.</p>
<p>For a dose given overseas that is missing from the NIR, submit a vaccination-record update through the NIR portal; CDA says, from <strong>12 May 2025</strong>, new additions or amendments are accepted through that portal. Include clear supporting records, and provide both the original and an English translation for documents not in English. CDA's FAQ gives an indicative processing time of about <strong>10 working days</strong> when documents are complete and legible, excluding weekends and public holidays; school-registration periods can take longer. A separate NIR service verifies vaccination records for a <strong>foreign-born child applying for a long-term stay in Singapore</strong>. This verification route is not the same as updating an existing record, and neither process by itself establishes that every overseas vaccine product is registered for local supply or tells a clinician which dose is next (<a href="https://www.nir.cda.gov.sg/eservices/parentalfaq">CDA NIR Parent FAQ, accessed Nov 2026</a>; <a href="https://www.cda.gov.sg/about-cda/contact-us/">CDA Contact, accessed Nov 2026</a>). For a child's clinical catch-up plan, consult a doctor; the schedule and the child's documentary record answer different questions.</p>
<h2>Current COVID-19 vaccination guidance and record boundaries</h2>
<p>From <strong>12 October 2026</strong>, COVID-19 vaccination was incorporated into both the National Childhood Immunisation Schedule (NCIS) and National Adult Immunisation Schedule (NAIS). MOH recommends it for people aged 60 and above, medically vulnerable people aged 6 months and above, and residents of aged-care facilities; healthcare workers and people living or working with medically vulnerable people are encouraged to receive it. Others aged six months and above who want vaccination may also receive it. This is a clinical recommendation, not a universal legal mandate (<a href="https://www.moh.gov.sg/newsroom/covid-19-vaccination-to-be-incorporated-into-national-immunisation-schedules/">MOH, 7 October 2026</a>).</p>
<p>For a first COVID-19 vaccination, an unvaccinated child aged 6 months to 4 years is recommended two doses eight weeks apart; an unvaccinated person aged 5 years or older is recommended one dose. People aged six months and above who were vaccinated previously are recommended an additional dose around one year after their last dose, and not earlier than five months. Updated XFG Moderna/Spikevax was rolled out from 12 October 2026 for ages 6 months and above; updated XFG Pfizer-BioNTech/Comirnaty was available from that date for ages 12 and above, and from 2 November 2026 for ages 6 months to 11 years. Availability at a particular clinic should be checked before visiting (<a href="https://www.moh.gov.sg/newsroom/covid-19-vaccination-to-be-incorporated-into-national-immunisation-schedules/">MOH, 7 October 2026</a>).</p>
<p>As of MOH's 7 October 2026 notice, COVID-19 vaccination remained fully subsidised, until further review, for Singapore citizens, permanent residents, Long-Term Pass holders and certain Short-Term Pass holders at participating CHAS GP clinics, polyclinics and Mobile Vaccination Team sites. The same notice says COVID-19 vaccination is not claimable under MediSave 500/700 or the MediSave Chronic and Preventive Care scheme from 1 January 2027, until further review. This is not a claim that every vaccine is free to every person at every provider; check the participating site's eligibility and availability before attending (<a href="https://www.moh.gov.sg/newsroom/covid-19-vaccination-to-be-incorporated-into-national-immunisation-schedules/">MOH, updated 6 November 2026</a>).</p>
<p>For overseas COVID-19 vaccinations, MOH allows clinics to enter records into the National Immunisation Registry (NIR) with acceptable documentary proof <strong>without serology testing or a digital certificate</strong>. This is a record-ingestion rule; it does not itself say that every foreign product is approved for use in Singapore or decide what dose a person should receive next. Since 1 March 2024, COVID-19 vaccination has also ceased to be a requirement for Permanent Residence, Long-Term Pass or Work Pass applications and renewals; vaccination remains encouraged (<a href="https://isomer-user-content.by.gov.sg/7/a5246b7a-6467-4680-827a-2217c3b57c4c/moh-cir-13-2024-integrating-our-covid-19-response-protocols-into-public-health-programmes.pdf">MOH Circular 13/2024</a>; <a href="https://www.mom.gov.sg/covid-19-vaccination-requirements-for-mom-passes">MOM, accessed 7 November 2026</a>).</p>
<h2>NEA and environmental public health</h2>
<p>The National Environment Agency is Singapore's national authority on <strong>environmental public health</strong> — the non-clinical layer of public health that keeps the physical environment from becoming a disease vector or contamination source (<a href="https://www.nea.gov.sg/corporate-functions/who-we-are/groups-and-divisions/public-health-groups-and-divisions">NEA, accessed Aug 2026</a>). NEA's public health pillar spans vector control, sanitation, food-hygiene enforcement, public cleanliness, port health, and after-death services. This is distinct from MOH/CDA's clinical epidemiology mandate but tightly coupled to it: mosquito abundance drives dengue risk, and food-hygiene lapses drive food-borne outbreaks.</p>
<p><strong>Food hygiene</strong> is a major NEA operational area. NEA licenses retail food establishments, inspects premises against the Code of Practice on Environmental Health (COPEH), and operates a Points Demerit System that can suspend licences after repeated lapses (<a href="https://www.nea.gov.sg/corporate-functions/who-we-are/groups-and-divisions/public-health-groups-and-divisions">NEA, accessed Aug 2026</a>). The <strong>Food Hygiene Recognition Scheme</strong> awards Bronze, Silver, or Gold decals to operators with consistent inspection track records of at least two, five, or ten years without major lapses — replacing the older annual A/B/C/D snapshot grading to reward sustained compliance (<a href="https://www.nea.gov.sg/media/readers-letters/index/new-grading-system-takes-into-account-the-track-record-of-eateries-from-every-hygiene-inspection">NEA, accessed Aug 2026</a>). Consumers can check suspension history and demerit points on NEA's Food Hygiene Information Portal. Food stall licences at hawker centres are issued by SFA, with NEA managing tenancy and environmental standards at NEA-managed <a href="/en/knowledge/article/sgkb.food-hawker-culture.hawker-centres">hawker centres</a> (<a href="https://www.nea.gov.sg/our-services/hawker-management/becoming-a-hawker">NEA hawker licensing, accessed Aug 2026</a>). SFA regulates food safety across the supply chain from import through manufacturing and distribution; NEA focuses on hygienic preparation and premises standards at the retail and food-service level.</p>
<p><strong>Vector control</strong> is NEA's other high-profile public health function. The Environmental Public Health Operations Group deploys regional offices for ground operations — inspections, enforcement, and outbreak intervention — while the Environmental Health Institute researches vector biology, runs Project Wolbachia (mass release of Wolbachia-infected male <em>Aedes aegypti</em> mosquitoes to suppress wild populations and reduce dengue transmission), and integrates case, vector, virus, and ecological surveillance into outbreak forecasting (<a href="https://www.nea.gov.sg/corporate-functions/who-we-are/groups-and-divisions/public-health-groups-and-divisions">NEA EHI, accessed Aug 2026</a>). NEA also oversees public cleanliness, environmental sanitation during infectious-disease outbreaks, and the Haze Task Force that coordinates inter-agency air-quality responses during transboundary haze episodes (see <a href="/en/knowledge/article/sgkb.environment-sustainability.haze">haze</a>).</p>
<h2>One Health coordination across agencies</h2>
<p>Singapore adopted a <strong>One Health</strong> approach in 2012, recognising that human, animal, and environmental health are linked — zoonotic diseases, food safety, antimicrobial resistance, and vector ecology do not respect agency boundaries (<a href="https://www.cda.gov.sg/public/one-health/singapore-one-health-master-plan/">CDA One Health, Dec 2025</a>). The <strong>Singapore One Health Master Plan</strong>, published in December 2025, sets the national strategy across three pillars: engagements (communications, networking, leadership), sector development (partnerships and education), and insights (research, information sharing, and surveillance). CDA, NEA, NParks, PUB, and SFA collaborated on the plan through workshops in 2024 and 2025 (<a href="https://www.cda.gov.sg/public/one-health/singapore-one-health-master-plan/">CDA One Health, Dec 2025</a>).</p>
<p>The framework's practical effects are everyday: integrated food safety from farm to hawker table; coordinated response when residents report sick wildlife; wastewater pathogen monitoring alongside clinical case counts; and joint rat-control enforcement with SFA at premises with poor refuse management (<a href="https://www.cda.gov.sg/public/one-health/singapore-one-health-master-plan/">CDA One Health, Dec 2025</a>; <a href="https://www.nea.gov.sg/corporate-functions/who-we-are/groups-and-divisions/public-health-groups-and-divisions">NEA, accessed Aug 2026</a>). ONEHealthSG branding unifies the inter-agency initiative. For residents, the distinction between agencies matters less than the outcome: clinical care when sick through <a href="/en/knowledge/article/sgkb.healthcare.polyclinics-and-primary-care">polyclinics and primary care</a> and <a href="/en/knowledge/article/sgkb.healthcare.hospitals">hospitals</a>, prevention through vaccination schedules and Healthier SG screenings, and environmental protection through NEA's inspection and vector-control regimes — all layers of a single public health defence.</p>